EVO

Evotec SE NASDAQ Listed Feb 5, 2004

Healthcare ·Drug Manufacturers - Specialty & Generic ·DE · evotec.com

$3.06

Mkt Cap $1.1B

52w Low $2.31 30.1% of range 52w High $4.80

50d MA $2.86 200d MA $3.38

P/E (TTM) -11.0x

EV/EBITDA -24.1x

P/B 1.4x

Debt/Equity 0.6x

ROE —

P/FCF -11.8x

RSI (14) —

ATR (14) —

Beta 1.24

50d MA $2.86

200d MA $3.38

Avg Volume 159.0K

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

SIC Code

2834

CIK (SEC)

1412558

Phone

49 40 560 81 0

Essener Bogen 7 · Hamburg 22419 · DE

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 8, 2026	TNS	0.21	0.06	-73.9%	2.69	-2.6%	-2.6%	-2.2%	+3.3%	+16.0%	+19.3%	—
Nov 5, 2025	TNS	-0.14	-0.14	-1.4%	3.35	+0.0%	-1.2%	-8.1%	-10.7%	-11.3%	-6.3%	—
Aug 13, 2025	TNS	-0.18	-0.14	+19.9%	3.81	+1.0%	+0.3%	-1.3%	-3.4%	-5.2%	-6.3%	—
May 6, 2025	TNS	-0.11	-0.20	-77.3%	4.05	+2.0%	+3.0%	-3.5%	+6.2%	+3.0%	+3.7%	—
Apr 17, 2025	TNS	0.02	-0.12	-768.4%	3.60	-3.6%	-0.6%	+10.3%	+13.6%	+16.9%	+17.2%	—
Nov 6, 2024	TNS	-0.08	-0.12	-50.0%	3.87	+9.6%	+9.8%	+6.7%	+25.8%	+14.7%	+17.6%	—
Aug 14, 2024	TNS	-0.09	-0.29	-222.2%	3.31	+0.3%	-3.6%	-1.5%	-3.0%	-3.3%	-6.3%	—
May 22, 2024	TNS	-0.03	-0.05	-49.6%	5.17	-3.7%	-4.6%	-7.7%	-6.0%	-11.4%	-12.6%	—
Feb 26, 2024	TNS	-0.03	-0.05	-66.7%	7.63	+0.7%	+0.3%	-1.8%	-3.0%	-1.3%	-5.6%	—
Nov 8, 2023	TNS	-0.05	-0.12	-140.0%	9.27	+5.1%	+4.0%	+0.6%	+1.3%	+8.6%	+8.1%	—
Aug 29, 2023	TNS	-0.04	-0.04	-10.8%	12.09	-1.8%	-0.6%	-2.1%	-2.3%	-5.1%	-4.1%	—
May 12, 2023	TNS	0.10	-0.08	-180.0%	10.19	+5.2%	+6.0%	+8.7%	+5.4%	+2.3%	+5.0%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Aug 14	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.81	$3.85	+1.0%	+0.3%	-1.3%	-3.4%	-5.2%	-6.3%
Nov 7	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.87	$4.24	+9.6%	+9.8%	+6.7%	+25.8%	+14.7%	+17.6%
Aug 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.31	$3.32	+0.3%	-3.6%	-1.5%	-3.0%	-3.3%	-6.3%
May 23	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.17	$4.98	-3.7%	-4.6%	-7.7%	-6.0%	-11.4%	-12.6%
Apr 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.23	$5.11	-2.3%	-2.5%	-4.0%	-0.6%	-0.8%	+0.4%
Aug 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$12.02	$11.74	-2.3%	-1.5%	-1.7%	-4.6%	-3.5%	-4.7%
Jul 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$11.91	$11.97	+0.5%	+1.3%	+2.8%	+3.4%	+3.5%	+7.1%
Jun 23	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$11.21	$11.45	+2.1%	+3.9%	-1.5%	-0.5%	+1.4%	-0.4%
Jun 16	BofA Securities	Downgrade	Buy → Neutral	—	$11.85	$11.77	-0.7%	-1.6%	-4.1%	-3.6%	-5.4%	-1.7%
Jun 8	Citigroup	Upgrade	Neutral → Buy	—	$11.26	$12.45	+10.6%	+10.8%	+8.4%	+10.1%	+8.2%	+4.5%
Apr 4	Morgan Stanley	Upgrade	Underweight → Equal Weight	—	$10.71	$10.81	+0.9%	+1.4%	+1.1%	+4.5%	+2.5%	-3.8%
Mar 29	HC Wainwright & Co.	Maintains	Buy → Buy	—	$10.14	$10.45	+3.1%	+1.2%	+3.1%	+3.1%	+5.6%	+7.1%
Jan 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$10.34	$10.14	-1.9%	-1.7%	-4.7%	-5.7%	-4.7%	+1.8%
Dec 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$8.38	$8.49	+1.3%	+0.5%	+1.4%	+1.3%	+0.8%	-3.8%
Nov 16	Deutsche Bank	Downgrade	Buy → Hold	—	$9.25	$9.01	-2.6%	-5.3%	-4.9%	-8.6%	-10.6%	-11.5%
Aug 10	Morgan Stanley	Downgrade	Overweight → Underweight	—	$14.13	$12.65	-10.5%	-7.1%	-7.0%	-1.1%	-2.3%	-3.0%
Nov 29	Cowen & Co.	Maintains	Outperform → Outperform	—	$23.73	$22.75	-4.1%	-4.2%	-0.7%	-3.5%	-2.7%	-5.2%
Aug 15	Stifel	Downgrade	Buy → Hold	—	$2.44	$2.42	-0.8%	-0.4%	+2.5%	+0.4%	+0.4%	+0.4%
Aug 14	Stifel	Downgrade	Buy → Hold	—	—	—	—	—	—	—	—	—

Data updated apr 26, 2026 10:32am · Source: massive.com